FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3012090411> ?p ?o ?g. }

• W3012090411 abstract "Abstract Compelling data have linked disease progression in patients with idiopathic pulmonary fibrosis (IPF) with lung dysbiosis and the resulting dysregulated local and systemic immune response. Moreover, prior therapeutic trials have suggested improved outcomes in these patients treated with either sulfamethoxazole/ trimethoprim or doxycycline. These trials have been limited by methodological concerns. This trial addresses the primary hypothesis that long-term treatment with antimicrobial therapy increases the time-to-event endpoint of respiratory hospitalization or all-cause mortality compared to usual care treatment in patients with IPF. We invoke numerous innovative features to achieve this goal, including: 1) utilizing a pragmatic randomized trial design; 2) collecting targeted biological samples to allow future exploration of ‘personalized’ therapy; and 3) developing a strong partnership between the NHLBI, a broad range of investigators, industry, and philanthropic organizations. The trial will randomize approximately 500 individuals in a 1:1 ratio to either antimicrobial therapy or usual care. The site principal investigator will declare their preferred initial antimicrobial treatment strategy (trimethoprim 160 mg/ sulfamethoxazole 800 mg twice a day plus folic acid 5 mg daily or doxycycline 100 mg once daily if body weight is < 50 kg or 100 mg twice daily if ≥50 kg) for the participant prior to randomization. Participants randomized to antimicrobial therapy will receive a voucher to help cover the additional prescription drug costs. Additionally, those participants will have 4–5 scheduled blood draws over the initial 24 months of therapy for safety monitoring. Blood sampling for DNA sequencing and genome wide transcriptomics will be collected before therapy. Blood sampling for transcriptomics and oral and fecal swabs for determination of the microbiome communities will be collected before and after study completion. As a pragmatic study, participants in both treatment arms will have limited in-person visits with the enrolling clinical center. Visits are limited to assessments of lung function and other clinical parameters at time points prior to randomization and at months 12, 24, and 36. All participants will be followed until the study completion for the assessment of clinical endpoints related to hospitalization and mortality events. Trial Registration ClinicalTrials.gov identifier NCT02759120 ." @default.
• W3012090411 created "2020-03-23" @default.
• W3012090411 creator A5003229389 @default.
• W3012090411 creator A5003881481 @default.
• W3012090411 creator A5006650120 @default.
• W3012090411 creator A5007796762 @default.
• W3012090411 creator A5008504819 @default.
• W3012090411 creator A5009091055 @default.
• W3012090411 creator A5009164132 @default.
• W3012090411 creator A5010115182 @default.
• W3012090411 creator A5015468225 @default.
• W3012090411 creator A5016658327 @default.
• W3012090411 creator A5042308557 @default.
• W3012090411 creator A5062088708 @default.
• W3012090411 creator A5071968251 @default.
• W3012090411 creator A5073529749 @default.
• W3012090411 creator A5076202429 @default.
• W3012090411 creator A5080197453 @default.
• W3012090411 creator A5080457552 @default.
• W3012090411 creator A5082568705 @default.
• W3012090411 date "2020-03-12" @default.
• W3012090411 modified "2023-09-27" @default.
• W3012090411 title "Design and rationale of a multi-center, pragmatic, open-label randomized trial of antimicrobial therapy – the study of clinical efficacy of antimicrobial therapy strategy using pragmatic design in Idiopathic Pulmonary Fibrosis (CleanUP-IPF) clinical trial" @default.
• W3012090411 cites W1817992190 @default.
• W3012090411 cites W1931781407 @default.
• W3012090411 cites W1938547050 @default.
• W3012090411 cites W1958471089 @default.
• W3012090411 cites W1968500926 @default.
• W3012090411 cites W1970008616 @default.
• W3012090411 cites W1974912764 @default.
• W3012090411 cites W1983018862 @default.
• W3012090411 cites W1984774336 @default.
• W3012090411 cites W1988755946 @default.
• W3012090411 cites W2002251042 @default.
• W3012090411 cites W2003201331 @default.
• W3012090411 cites W2003545901 @default.
• W3012090411 cites W2003788939 @default.
• W3012090411 cites W2007922312 @default.
• W3012090411 cites W2058041469 @default.
• W3012090411 cites W2058129410 @default.
• W3012090411 cites W2063946490 @default.
• W3012090411 cites W2080677332 @default.
• W3012090411 cites W2081574718 @default.
• W3012090411 cites W2081945827 @default.
• W3012090411 cites W2084870214 @default.
• W3012090411 cites W2103221430 @default.
• W3012090411 cites W2111194699 @default.
• W3012090411 cites W2112908451 @default.
• W3012090411 cites W2114242035 @default.
• W3012090411 cites W2116103373 @default.
• W3012090411 cites W2119845256 @default.
• W3012090411 cites W2122574927 @default.
• W3012090411 cites W2128659393 @default.
• W3012090411 cites W2138871107 @default.
• W3012090411 cites W2138898755 @default.
• W3012090411 cites W2143294512 @default.
• W3012090411 cites W2143391838 @default.
• W3012090411 cites W2145720531 @default.
• W3012090411 cites W2146139012 @default.
• W3012090411 cites W2157930142 @default.
• W3012090411 cites W2164981395 @default.
• W3012090411 cites W2168666423 @default.
• W3012090411 cites W2170025913 @default.
• W3012090411 cites W2171738220 @default.
• W3012090411 cites W2315538569 @default.
• W3012090411 cites W2535688063 @default.
• W3012090411 cites W2550523848 @default.
• W3012090411 cites W2577072690 @default.
• W3012090411 cites W2585707392 @default.
• W3012090411 cites W2591274003 @default.
• W3012090411 cites W2604367936 @default.
• W3012090411 cites W2605622762 @default.
• W3012090411 cites W2611007056 @default.
• W3012090411 cites W2611562788 @default.
• W3012090411 cites W2661861904 @default.
• W3012090411 cites W2721901041 @default.
• W3012090411 cites W2755069867 @default.
• W3012090411 cites W2787246236 @default.
• W3012090411 cites W2799479598 @default.
• W3012090411 cites W2804017805 @default.
• W3012090411 cites W2883404399 @default.
• W3012090411 cites W2889197569 @default.
• W3012090411 cites W2903294287 @default.
• W3012090411 cites W2917666184 @default.
• W3012090411 cites W2921099624 @default.
• W3012090411 doi "https://doi.org/10.1186/s12931-020-1326-1" @default.
• W3012090411 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7069004" @default.
• W3012090411 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32164673" @default.
• W3012090411 hasPublicationYear "2020" @default.
• W3012090411 type Work @default.
• W3012090411 sameAs 3012090411 @default.
• W3012090411 citedByCount "15" @default.
• W3012090411 countsByYear W30120904112020 @default.
• W3012090411 countsByYear W30120904112021 @default.
• W3012090411 countsByYear W30120904112022 @default.
• W3012090411 crossrefType "journal-article" @default.
• W3012090411 hasAuthorship W3012090411A5003229389 @default.
• W3012090411 hasAuthorship W3012090411A5003881481 @default.
• W3012090411 hasAuthorship W3012090411A5006650120 @default.
• W3012090411 hasAuthorship W3012090411A5007796762 @default.

• next